Gujarat Kidney IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
No GMP observations are available for this historical offer record. No premium or listing-gain estimate is shown.
Price band
₹108 – ₹114
Lot size
128 shares
Offer application amount
₹14,592
Issue size
₹250.8 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 22 Dec 2025 |
| Close date | 24 Dec 2025 |
| Allotment finalisation | 26 Dec 2025 |
| Refund initiation | 29 Dec 2025 |
| Shares credited to demat | 29 Dec 2025 |
| Reported listing date | 30 Dec 2025 |
Issue size
About Gujarat Kidney
Gujarat Kidney and Super Speciality Limited (GKASSL), founded in 2019, is one of the leading companies that provides multispeciality healthcare services. The company has multiple hospitals situated across Gujarat, India. Its main services include Secondary Care Services and Tertiary Care Services. Internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology are some of the medical care offered by the company.
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Use of proceeds
| Proposed acquisition of Parekhs Hospital at Ahmedabad. | ₹77.00 |
| Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. | ₹12.40 |
| Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. | ₹30.10 |
| Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. | ₹6.83 |
| Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company | ₹1.20 |
| Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. | ₹- |
| Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch | ₹10.78 |
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.